Search Results
Mar 29, 2026, 08:14 ET RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:13 ET PMI DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. ("Picard" or the "Company") (NYSE: PMI) and reminds investors of the April 13,
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:11 ET TCOM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Trip.com Group (TCOM) Investors of Securities Class Action Deadline on May 11, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Trip.com Group Limited ("Trip.com" or the "Company") (NASDAQ: TCOM) and reminds investors of the May
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:08 ET RR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Richtech Robotics Investors of the Securities Class Action Lawsuit Deadline on April 3, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ: RR) and reminds investors of the April
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:07 ET RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO Investors of Securities Class Action Deadline on April 14, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against REGENXBIO Inc. ("REGENXBIO" or the "Company") (NASDAQ: RGNX) and reminds investors of the April 14,
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:05 ET METC DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ramaco Investors of Securities Class Action Deadline on March 31, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ: METC) and reminds investors of the March
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:01 ET POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM) and reminds investors of the April
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 04:51 ET ENPH DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Enphase Energy Investors of Securities Class Action Deadline on April 20, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enphase Energy, Inc. ("Enphase" or the "Company") (NASDAQ: ENPH) and reminds investors of the April
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 19:47 ET HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1,
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 19:30 ET PSIX Investors Have Opportunity to Lead Power Solutions International, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Power Solutions International, Inc. (NASDAQ: PSIX)
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 18:35 ET LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm
refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time,
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 18:04 ET FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved at that time,
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 15:31 ET ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit
refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time,
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 15:20 ET INVESTOR ALERT: Trip.com Group Limited (TCOM) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, March 28, 2026 /PRNewswire/ -- The law firm of
More news about: Robbins Geller Rudman & Dowd LLP
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with,
More news about: Eli Lilly and Company
Mar 28, 2026, 14:16 ET SMR Investors Have Opportunity to Lead NuScale Power Corporation Securities Fraud Lawsuit
refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time,
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 14:01 ET /C O R R E C T I O N -- Nestlé/
to not attempt to locate, handle or recover any stolen goods and to not take any direct action. Any relevant information should be shared with local law enforcement authorities.KITKAT will continue to support the investigation and provide further updates as appropriate.Notes To Editors1.
More news about: Nestlé
Mar 28, 2026, 11:20 ET NuScale Power Corporation (SMR) Class Action Lawsuit: Investors Face March 13, 2026, Deadline
accolades, including The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 28, 2026, 11:05 ET TCOM Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages TCOM Investors with Losses to Contact the Firm
accolades, including The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 28, 2026, 10:55 ET CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements, except as required by law. This cautionary statement is applicable to all forward-looking statements contained in this document.CONTACTS:Kirsten Lesak-GreenbergMedia
More news about: Boston Scientific Corporation
Mar 28, 2026, 10:52 ET HTGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Hercules Capital (HTGC) Investors of Securities Class Action Deadline on May 19, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hercules Capital, Inc. ("Hercules Capital" or the "Company") (NYSE: HTGC) and reminds investors of the
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:49 ET HELE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Helen of Troy
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Helen of Troy Limited ("Helen of Troy" or the "Company") (NASDAQ: HELE).
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:44 ET SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) and reminds investors of the May
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:44 ET GO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grocery Outlet (GO) Investors of Securities Class Action Deadline on May 15, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO) and reminds investors of
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:42 ET ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA) and reminds investors of the May
More news about: Faruqi & Faruqi, LLP